Literature DB >> 22891289

Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cells.

Sara M Centuori1, Malika Trad, Collin J LaCasse, Darya Alizadeh, Claire B Larmonier, Neale T Hanke, Jessica Kartchner, Nona Janikashvili, Bernard Bonnotte, Nicolas Larmonier, Emmanuel Katsanis.   

Abstract

MDSCs and Tregs play an essential role in the immunosuppressive networks that contribute to tumor-immune evasion. The mechanisms by which tumors promote the expansion and/or function of these suppressive cells and the cross-talk between MDSC and Treg remain incompletely defined. Previous reports have suggested that MDSC may contribute to Treg induction in cancer. Herein, we provide evidence that tumor-induced gr-MDSCs, endowed with the potential of suppressing conventional T Lc, surprisingly impair TGF-β1-mediated generation of CD4(+)CD25(+)FoxP3(+) iTregs. Furthermore, gr-MDSCs impede the proliferation of nTregs without, however, affecting FoxP3 expression. Suppression of iTreg differentiation from naïve CD4(+) cells by gr-MDSC occurs early in the polarization process, requires inhibition of early T cell activation, and depends on ROS and IDO but does not require arginase 1, iNOS, NO, cystine/cysteine depletion, PD-1 and PD-L1 signaling, or COX-2. These findings thus indicate that gr-MDSCs from TB hosts have the unanticipated ability to restrict immunosuppressive Tregs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22891289      PMCID: PMC3476240          DOI: 10.1189/jlb.0911465

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  55 in total

Review 1.  Regulation of immunity by self-reactive T cells.

Authors:  Mitchell Kronenberg; Alexander Rudensky
Journal:  Nature       Date:  2005-06-02       Impact factor: 49.962

Review 2.  Regulatory T cells, tumour immunity and immunotherapy.

Authors:  Weiping Zou
Journal:  Nat Rev Immunol       Date:  2006-04       Impact factor: 53.106

Review 3.  Role of immature myeloid cells in mechanisms of immune evasion in cancer.

Authors:  Sergei Kusmartsev; Dmitry I Gabrilovich
Journal:  Cancer Immunol Immunother       Date:  2005-07-27       Impact factor: 6.968

4.  Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host.

Authors:  Bo Huang; Ping-Ying Pan; Qingsheng Li; Alice I Sato; David E Levy; Jonathan Bromberg; Celia M Divino; Shu-Hsia Chen
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

5.  Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells.

Authors:  Manuelle Viguier; Fabrice Lemaître; Olivier Verola; Min-Sun Cho; Guy Gorochov; Louis Dubertret; Hervé Bachelez; Philippe Kourilsky; Laurent Ferradini
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

6.  Imatinib mesylate inhibits CD4+ CD25+ regulatory T cell activity and enhances active immunotherapy against BCR-ABL- tumors.

Authors:  Nicolas Larmonier; Nona Janikashvili; Collin James LaCasse; Claire Billerey Larmonier; Jessica Cantrell; Elaine Situ; Tamara Lundeen; Bernard Bonnotte; Emmanuel Katsanis
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

7.  Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses.

Authors:  Paulo C Rodriguez; David G Quiceno; Jovanny Zabaleta; Blair Ortiz; Arnold H Zea; Maria B Piazuelo; Alberto Delgado; Pelayo Correa; Jason Brayer; Eduardo M Sotomayor; Scott Antonia; Juan B Ochoa; Augusto C Ochoa
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

8.  CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative.

Authors:  François Ghiringhelli; Nicolas Larmonier; Elise Schmitt; Arnaud Parcellier; Dominique Cathelin; Carmen Garrido; Bruno Chauffert; Eric Solary; Bernard Bonnotte; François Martin
Journal:  Eur J Immunol       Date:  2004-02       Impact factor: 5.532

9.  Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity.

Authors:  Cecilia Melani; Claudia Chiodoni; Guido Forni; Mario P Colombo
Journal:  Blood       Date:  2003-05-15       Impact factor: 22.113

10.  Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

Authors:  Sergei Kusmartsev; Yulia Nefedova; Daniel Yoder; Dmitry I Gabrilovich
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

View more
  35 in total

1.  Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model.

Authors:  J Yan; C Tingey; R Lyde; T C Gorham; D K Choo; A Muthumani; D Myles; L P Weiner; K A Kraynyak; E L Reuschel; T H Finkel; J J Kim; N Y Sardesai; K E Ugen; K Muthumani; D B Weiner
Journal:  Cancer Gene Ther       Date:  2014-11-14       Impact factor: 5.987

Review 2.  Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer.

Authors:  Sabrin Husein Albeituni; Chuanlin Ding; Jun Yan
Journal:  Cancer J       Date:  2013 Nov-Dec       Impact factor: 3.360

Review 3.  Phenotype, development, and biological function of myeloid-derived suppressor cells.

Authors:  Yang Zhao; Tingting Wu; Steven Shao; Bingyi Shi; Yong Zhao
Journal:  Oncoimmunology       Date:  2015-10-14       Impact factor: 8.110

4.  Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotype.

Authors:  Natascha Köstlin; Margit Vogelmann; Bärbel Spring; Julian Schwarz; Judith Feucht; Christoph Härtel; Thorsten W Orlikowsky; Christian F Poets; Christian Gille
Journal:  Immunology       Date:  2017-06-08       Impact factor: 7.397

5.  Extracorporeal photopheresis increases neutrophilic myeloid-derived suppressor cells in patients with GvHD.

Authors:  N Rieber; I Wecker; D Neri; K Fuchs; I Schäfer; A Brand; M Pfeiffer; P Lang; W Bethge; O Amon; R Handgretinger; D Hartl
Journal:  Bone Marrow Transplant       Date:  2014-01-27       Impact factor: 5.483

6.  Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonist attenuate tumor growth via polarization of neutrophils toward an antitumor phenotype.

Authors:  Sanjeeb Shrestha; Jae Myoung Noh; Shin-Yeong Kim; Hwa-Yong Ham; Yeon-Ja Kim; Young-Jin Yun; Min-Ju Kim; Min-Soo Kwon; Dong-Keun Song; Chang-Won Hong
Journal:  Oncoimmunology       Date:  2015-08-12       Impact factor: 8.110

Review 7.  Regulation of tumor metastasis by myeloid-derived suppressor cells.

Authors:  Thomas Condamine; Indu Ramachandran; Je-In Youn; Dmitry I Gabrilovich
Journal:  Annu Rev Med       Date:  2014-10-09       Impact factor: 13.739

Review 8.  Innate sensing of cancer's non-immunologic hallmarks.

Authors:  Ruth Seelige; Stephen Searles; Jack D Bui
Journal:  Curr Opin Immunol       Date:  2017-10-12       Impact factor: 7.486

9.  Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer.

Authors:  Darya Alizadeh; Malika Trad; Neale T Hanke; Claire B Larmonier; Nona Janikashvili; Bernard Bonnotte; Emmanuel Katsanis; Nicolas Larmonier
Journal:  Cancer Res       Date:  2013-11-06       Impact factor: 12.701

Review 10.  Signaling pathways involved in MDSC regulation.

Authors:  Prashant Trikha; William E Carson
Journal:  Biochim Biophys Acta       Date:  2014-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.